Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 7/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8849877 | 0.82 | ALDH1A1 (0.52) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL6421553 | 0.82 | ALDH1A1 (0.52) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL891719 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL2033070 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL28438522 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL8849031 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL15805876 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL15798224 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL9814483 | 0.77 | THRB (0.46) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL15805828 | 0.77 | THRB (0.46) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2931768-B1 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ANGUS CHEMICAL (US) | 2017-08-16 | — | — | EP | claimed |
| US-9676957-B2 | Nitrofunctional acrylate copolymers for binder compositions | ANGUS CHEMICAL COMPANY (US) | 2017-06-13 | — | — | US | claimed |
| US-9670134-B2 | Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters | ANGUS CHEMICAL COMPANY (US) | 2017-06-06 | — | — | US | claimed |
| US-20160046558-A1 | SYNTHESIS OF (2-NITRO)ALKYL (METH)ACRYLATES VIA TRANSESTERIFICATION OF (METH)ACRYLATE ESTERS | ADVANCION CORPORATION | 2016-02-18 | — | — | US | claimed |
| US-20150322281-A1 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ADVANCION CORPORATION | 2015-11-12 | — | — | US | claimed |
| EP-2931768-A1 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ANGUS Chemical Company (US) | 2015-10-21 | — | — | EP | claimed |
| WO-2014158445-A1 | SYNTHESIS OF (2-NITRO)ALKYL (METH)ACRYLATES VIA TRANSESTERIFICATION OF (METH)ACRYLATE ESTERS | ROHM AND HAAS COMPANY (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014092914-A1 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ANGUS CHEMICAL COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-9676957-B2 | Nitrofunctional acrylate copolymers for binder compositions | ANGUS CHEMICAL COMPANY (US) | 2017-06-13 | — | — | US | disclosed |
| EP-3121206-A2 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ANGUS Chemical Company (US) | 2017-01-25 | — | — | EP | disclosed |
| US-20150322281-A1 | NITROFUNCTIONAL ACRYLATE COPOLYMERS FOR BINDER COMPOSITIONS | ADVANCION CORPORATION | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046558-A1 | SYNTHESIS OF (2-NITRO)ALKYL (METH)ACRYLATES VIA TRANSESTERIFICATION OF (METH)ACRYLATE ESTERS | NAT1, NOS2, NOS1 | ALDH1A1 43/4885TP53 3078/4885HIF1A 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.